Many recalls are initiated due to the potential risk of contamination in the food product. Here's what was pulled from ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's drug to treat some patients aged 12 years and older ...

Health and Human Services employees were told in March to remove nicknames from email systems and signatures to comply with ...

British animal genetics company Genus on Wednesday said the U.S. Food and Drug Administration (FDA) approved its PRP gene ...

Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

The FDA doesn’t plan to execute a reorganization of the agency but will consolidate offices that handle travel, technology, ...

An urgent recall for hundreds of cases of frozen bread sold throughout the U.S. was issued after the FDA said "glass ...

Nipocalimab (Imaavy; Johnson & Johnson), an FcRn-blocking monoclonal antibody, was approved for patients 12 years and older ...